Pick 2–10 funds, stocks or ETFs to see their returns, risk, costs and highlights on one page
| Fund | ||||||||
|---|---|---|---|---|---|---|---|---|
| 600276.SS | −28.75% | +6.16% | +6.51% | +1.00% | −11.67% | −22.00% | −29.93% | −7.75% |
| UCHI | −2.77% | +0.86% | −1.59% | −10.84% | −0.28% | −2.42% | −9.22% | +9.85% |
| BCARE | +15.51% | +1.80% | +5.35% | +6.78% | +7.18% | +17.90% | +24.01% | +44.46% |
| SCBRMGHC | +10.74% | +2.25% | +5.00% | +6.38% | +3.73% | +14.65% | +20.10% | +43.11% |
* Fewer than 12 months: the year the fund started reporting NAV, or the current year
Counts only the top holdings with available data, not the whole portfolio · Pick a pair below for details
Excludes 600276.SS: money market or bond funds, or no holdings data yet
| BCARE | SCBRMGHC | |
|---|---|---|
| Held by both | ||
 Eli Lilly and Co | 8.44% | 9.70% |
 Johnson & Johnson | 4.76% | 7.85% |
 AstraZeneca | 3.87% | 3.74% |
 Unitedhealth Group | 2.88% | 4.31% |
 ABBVIE | 2.48% | 4.98% |
 Merck & | 5.46% | 2.37% |
| Only in BCARE | ||
 GSK | 2.48% | N/A |
 Intuitive Surgical | 2.38% | N/A |
 Vertex Pharmaceuticals | 2.28% | N/A |
 Elevance Health | 2.28% | N/A |
| Only in SCBRMGHC | ||
 Thermo Fisher | N/A | 3.38% |
 Novartis | N/A | 2.76% |
 Roche | N/A | 2.70% |
 argenx | N/A | 2.47% |
30 Dec 2025 → 30 Oct 2026
| Fund | Return per year | Volatility per year | Sharpe |
|---|---|---|---|
| BCARE | +15.51% | 15.99% | 0.97 |
| SCBRMGHC | +10.74% | 16.87% | 0.64 |
| UCHI | −2.77% | 29.74% | −0.09 |
| 600276.SS | −28.75% | 43.73% | −0.66 |
Sharpe here = annual return ÷ annual volatility, without deducting the risk-free rate, calculated from NAV over the selected period · Periods shorter than 1 year use the cumulative return instead of the annual return
| Drag a column header to reorder | 600276.SS | UCHI | BCARE | SCBRMGHC |
|---|---|---|---|---|
Fund details | ||||
| Fund size | N/A | 699 million | 4,742 million | 2,422 million |
| Inception date | N/A | 25 Feb 2021 | 29 Aug 2007 | 6 Nov 2015 |
| Master fund | N/A | กองทุนที่ลงทุนหลายกอง (Global X China Biotech, Kraneshares MSCI All China Health Care Index) | Wellington Global Health Care Equity Fund | Janus Henderson Global Life Sciences Fund |
| Dividend policy | N/A | Does not pay | Does not pay | Does not pay |
Risk and currency hedging | ||||
| Risk level | N/A | 7 | 7 | 7 |
| Hedging policy | N/A | Hedged at the manager's discretion | Hedged at the manager's discretion | Almost fully hedged |
| Share hedged | N/A | 89.92% | 47.41% | 100.58% |
Minimum purchase and redemption | ||||
| First purchase | N/A | 0.01 THB | 500 THB | 1,000 THB |
| Subsequent purchase | N/A | 0.01 THB | 500 THB | 1,000 THB |
| Redemption (amount) | N/A | 0.01 THB | No minimum | 1,000 THB |
| Redemption (units) | N/A | No minimum | No minimum | No minimum |
| Balance (amount) | N/A | No minimum | No minimum | 1,000 THB |
| Balance (units) | N/A | No minimum | No minimum | No minimum |
Order cut-off and redemption payment | ||||
| Buy before | N/A | 15:30 | 15:30 | 15:30 |
| Redeem before | N/A | 14:00 | 15:30 | 15:30 |
| Redemption paid | N/A | T+4 | T+4 | T+5 |
